Renaissance Technologies’s SQZ Biotechnologies Company SQZ Stock Holding History

Renaissance Technologies’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-83,603	Closed	-$23K	–	4311
2023 Q2	$23K	Buy	83,603 +9,300	+13%	+$5.28K	﹤0.01%	3752
2023 Q1	$42K	Sell	74,303 -39,725	-35%	-$29.3K	﹤0.01%	3702
2022 Q4	$84K	Buy	114,028 +55,425	+95%	+$121K	﹤0.01%	3676
2022 Q3	$134K	Buy	58,603 +700	+1%	+$2.1K	﹤0.01%	3505
2022 Q2	$184K	Buy	+57,903	New	+$208K	﹤0.01%	3682

Other funds holding SQZ

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

BSB

Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies's SQZ Position: Q3 2023 in Review

Renaissance Technologies sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 83,603 shares — an estimated $23K sold.

Renaissance Technologies first reported a position in SQZ in Q2 2022 and held it in 5 quarters. The position peaked at $184K in Q2 2022. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

Renaissance Technologies reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
Renaissance Technologies sold 83,603 SQZ Biotechnologies Company shares in Q3 2023, an estimated $23K.
Renaissance Technologies first reported a position in SQZ Biotechnologies Company in Q2 2022 and held it in 5 quarters.
Renaissance Technologies's SQZ Biotechnologies Company position peaked at $184K in Q2 2022.
5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.